Trinity Financial Advisors LLC trimmed its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 32.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 409 shares of the biotechnology company’s stock after selling 200 shares during the quarter. Trinity Financial Advisors LLC’s holdings in Axon Enterprise were worth $339,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock worth $4,540,005,000 after acquiring an additional 185,571 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Axon Enterprise by 15.9% during the first quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company’s stock worth $675,812,000 after acquiring an additional 175,890 shares during the last quarter. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock worth $487,977,000 after acquiring an additional 212,931 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Axon Enterprise by 58,725.5% during the first quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company’s stock worth $402,210,000 after acquiring an additional 763,431 shares during the last quarter. Finally, Northern Trust Corp raised its position in shares of Axon Enterprise by 1.2% during the first quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company’s stock worth $381,692,000 after acquiring an additional 8,794 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on AXON shares. Bank of America raised their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Wolfe Research initiated coverage on Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating for the company. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a report on Tuesday, August 5th. UBS Group reiterated a “neutral” rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an “overweight” rating in a report on Friday, July 11th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $837.69.
Axon Enterprise Trading Up 0.7%
Shares of Axon Enterprise stock opened at $756.13 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52 week low of $375.71 and a 52 week high of $885.91. The stock has a 50 day moving average price of $761.10 and a two-hundred day moving average price of $687.25. The stock has a market capitalization of $59.36 billion, a PE ratio of 186.70, a price-to-earnings-growth ratio of 27.57 and a beta of 1.40.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter last year, the firm posted $1.20 earnings per share. The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $743.64, for a total value of $7,436,400.00. Following the completion of the sale, the chief executive officer owned 3,043,982 shares of the company’s stock, valued at approximately $2,263,626,774.48. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $723.50, for a total value of $54,262.50. Following the completion of the sale, the chief accounting officer directly owned 15,080 shares of the company’s stock, valued at $10,910,380. This trade represents a 0.49% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,790 shares of company stock valued at $34,304,947. Company insiders own 4.40% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- Insider Buying Explained: What Investors Need to Know
- Ride the Luxury Retail Wave with These 3 High-End Brand Stocks
- What is the Australian Securities Exchange (ASX)
- Wall Street Quietly Bets Big on These Chinese Tech Giants
- Dividend Payout Ratio Calculator
- Meta’s $600B U.S. Investment: Bearish or Bullish for Shares?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
